H.R. 8205

Status: Passed House

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Sponsored by Mike Quigley (Democrat-IL-5)

Topics

Cosponsors

103

Actions

22

Roll calls

0

Amendments

0

Related bills

2

Actions

Apr 6, 2026 · House floor actions

Referred to the House Committee on Energy and Commerce.

Apr 6, 2026 · House committee actions

Referred to the Subcommittee on Health.

Latest activity

July 2026

Bill passed chamber · Jul 22Passed House

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Bill passed chamber · Jul 22Passed House

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Lobbying reported · The ALS Association · Jul 20

The ALS Association reported 2nd Quarter (Apr 1 - June 30) lobbying for The ALS Association — $30,000

Lobbying reported · Twenty-First Century Group · Jul 20

Twenty-First Century Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Nrx Pharmaceuticals — $24,000

BillsH.R. 8205 H.R. 8646 H.R. 9495 S. 4472

Lobbying reported · Muscular Dystrophy Association · Jul 16

Muscular Dystrophy Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Muscular Dystrophy Association — $60,000

BillsH.R. 8205 S. 4472

Lobbying reported · I Am Als · Jul 13

I Am Als reported 2nd Quarter (Apr 1 - June 30) lobbying for I Am Als — $30,000

BillsH.R. 1685 H.R. 2036 H.R. 4016 H.R. 4121 H.R. 4206 H.R. 6001 H.R. 7336 H.R. 7779 H.R. 8205 H.R. 9237 S. 749 S. 925 S. 1261 S. 2256 S. 2572 S. 2587 S. 4472 S. 4744

You’re all caught up.